Insulin: Medical Uses, Benefits, and Central Role in Diabetes Management

Primary Medical Uses of Insulin

1. Diabetes Mellitus Treatment

  • Type 1 Diabetes: Absolute insulin deficiency (autoimmune β-cell destruction). Lifelong exogenous insulin is survival-critical. Regimens: basal-bolus (MDI), insulin pump (CSII), automated insulin delivery (AID/hybrid closed-loop).
  • Type 2 Diabetes: Progressive β-cell failure + insulin resistance. Insulin initiated when: HbA1c > target on max oral/non-insulin therapy; significant hyperglycemia at diagnosis (HbA1c >10% or symptomatic); during hospitalization, surgery, acute illness, steroid therapy; pregnancy; contraindications to other agents.

2. Diabetic Emergencies

  • Diabetic Ketoacidosis (DKA): IV regular insulin infusion (0.1 U/kg/hr) + fluids + electrolytes — corrects hyperglycemia, ketosis, acidosis.
  • Hyperglycemic Hyperosmolar State (HHS): IV insulin + aggressive fluid resuscitation — lowers severe hyperosmolality.

3. Gestational Diabetes (GDM)

Insulin is the preferred pharmacological agent when medical nutrition therapy + exercise fail—does not cross placenta, unlike most oral agents. Safe for fetus.

4. Hyperglycemia in Critical Illness

Stress hyperglycemia in ICU (with or without prior diabetes) managed with IV insulin protocols (target 140–180 mg/dL) → improves mortality, infection, LOS.

5. Research Applications

Essential tool for studying glucose metabolism, insulin signaling, β-cell function, insulin resistance mechanisms, and novel therapies (β-cell replacement, immunotherapy).

Insulin Formulations & Advances

Impact & Future

Insulin transformed T1D from fatal to manageable. Advances: concentrated insulins (U200, U300, U500), inhaled insulin (Afrezza), smart pens, CGM-integrated pumps (AID systems), glucose-responsive "smart" insulin (experimental). Access remains a global crisis—advocacy for affordable insulin continues.

Diabetes - Related Articles

Health Sciences © https://www.222health.com

TypeOnsetPeakDurationExamples
Rapid-acting analogs5–15 min30–90 min3–5 hrsLispro, Aspart, Glulisine, Faster aspart
Short-acting (Regular)30–60 min2–4 hrs6–8 hrsHuman Regular
Intermediate (NPH)1–2 hrs4–10 hrs10–18 hrsNPH (Neutral Protamine Hagedorn)
Long-acting analogs1–2 hrsPeakless24–42 hrsGlargine U100/U300, Degludec
Ultra-long1 hrPeakless>42 hrsDegludec
PremixedVariesDual peak12–24 hrs70/30, 75/25, 50/50